A randomized placebo-controlled clinical trial investigating the effects of Liraglutide as an
add-on to intensive insulin therapy in overweight insulin pump treated type 1 diabetes
patients in suboptimal glycemic control.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Hvidovre University Hospital
Collaborators:
Steno Diabetes Center Steno Diabetes Center Copenhagen